Driven by the rising cardiac disease prevalence, growing demand for continuous monitoring, and the rapid adoption of artificial intelligence (AI)-enabled wearable technologies, the cardiovascular monitoring devices market in India is projected to reach $153 million in 2036, forecasts GlobalData, a leading data and analytics company.

GlobalData’s report, “Cardiovascular Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036,” reveals that India is one of the fastest-growing markets in the Asia-Pacific (APAC) region, representing 7% of the region in 2025.

Sarvesh Kumar, Medical Devices Analyst at GlobalData, comments: “The rising burden of cardiovascular diseases and the shift toward connected, AI-driven monitoring platforms are prompting sustained investment in India’s cardiac diagnostics space. Manufacturers are now prioritizing smart, patient-friendly devices that deliver higher clinical accuracy and meet the needs of both hospitals and home-care settings.”

The launch of vCardio, an AI-powered wearable cardiac monitor developed by Chennai-based vTitan, exemplifies this trend. Designed as a single-lead, lightweight device, vCardio enables continuous ECG capture and uses cloud-integrated AI algorithms to detect and classify over 20 clinically relevant arrhythmias. Such innovations are enhancing diagnostic precision, streamlining workflows, and expanding opportunities for remote monitoring and long-term cardiac risk management.

However, the market continues to face challenges, including limited access to trained cardiac specialists in rural regions, inconsistent reimbursement coverage for advanced monitoring devices, and high deployment costs in smaller healthcare facilities.

Kumar concludes: “Growth opportunities may be unlocked through better reimbursement support, increased participation from private diagnostic networks, and workforce development programs that strengthen cardiac screening capabilities across India. These improvements could allow a wider patient population to benefit from advanced cardiovascular monitoring technologies, supporting steady market expansion through 2036.”